{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:41:02Z","timestamp":1740123662224,"version":"3.37.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan","award":["ONC-BRCA-001\/002"],"award-info":[{"award-number":["ONC-BRCA-001\/002"]}]},{"DOI":"10.13039\/100008658","name":"Deutsches Krebsforschungszentrum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008658","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s10689-022-00304-1","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T09:03:24Z","timestamp":1657271004000},"page":"31-41","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence of FANCM germline variants in BRCA1\/2 negative breast and\/or ovarian cancer patients from Pakistan"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7684-3122","authenticated-orcid":false,"given":"Muhammad Usman","family":"Rashid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noor","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umara","family":"Shehzad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faiz Ali","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asif","family":"Loya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ute","family":"Hamann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,8]]},"reference":[{"issue":"3","key":"304_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL (2021) Global cancer statistics 2020 GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J clin"},{"key":"304_CR2","doi-asserted-by":"publisher","first-page":"8145","DOI":"10.2147\/CMAR.S208323","volume":"11","author":"S Mubarik","year":"2019","unstructured":"Mubarik S, Malik SS, Wang Z, Li C, Fawad M, Yu C (2019) Recent insights into breast cancer incidence trends among four Asian countries using age-period-cohort model. Cancer Manag Res 11:8145\u20138155. https:\/\/doi.org\/10.2147\/CMAR.S208323","journal-title":"Cancer Manag Res"},{"issue":"1","key":"304_CR3","doi-asserted-by":"publisher","first-page":"5480","DOI":"10.1038\/s41598-020-62393-1","volume":"10","author":"S Mubarik","year":"2020","unstructured":"Mubarik S, Wang F, Fawad M (2020) Trends and projections in breast cancer mortality among four Asian countries (1990\u20132017): evidence from five stochastic mortality models. Sci Rep 10(1):5480. https:\/\/doi.org\/10.1038\/s41598-020-62393-1","journal-title":"Sci Rep"},{"issue":"5581","key":"304_CR4","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1126\/science.1073834","volume":"297","author":"NG Howlett","year":"2002","unstructured":"Howlett NG, Taniguchi T, Olson S et al (2002) Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297(5581):606\u2013609. https:\/\/doi.org\/10.1126\/science.1073834","journal-title":"Science"},{"issue":"9","key":"304_CR5","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/ng1624","volume":"37","author":"O Levran","year":"2005","unstructured":"Levran O, Attwooll C, Henry RT et al (2005) The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. Nat Genet 37(9):931\u2013933. https:\/\/doi.org\/10.1038\/ng1624","journal-title":"Nat Genet"},{"issue":"6","key":"304_CR6","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.molcel.2006.05.022","volume":"22","author":"B Xia","year":"2006","unstructured":"Xia B, Sheng Q, Nakanishi K et al (2006) Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol Cell 22(6):719\u2013729. https:\/\/doi.org\/10.1016\/j.molcel.2006.05.022","journal-title":"Mol Cell"},{"issue":"5","key":"304_CR7","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/ng.570","volume":"42","author":"F Vaz","year":"2010","unstructured":"Vaz F, Hanenberg H, Schuster B et al (2010) Mutation of the RAD51C gene in a Fanconi anemia-like disorder. Nat Genet 42(5):406\u2013409. https:\/\/doi.org\/10.1038\/ng.570","journal-title":"Nat Genet"},{"issue":"2","key":"304_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1158\/2159-8290.CD-14-1156","volume":"5","author":"SL Sawyer","year":"2015","unstructured":"Sawyer SL, Tian L, K\u00e4hk\u00f6nen M et al (2015) Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype. Cancer Discov 5(2):135\u2013142. https:\/\/doi.org\/10.1158\/2159-8290.CD-14-1156","journal-title":"Cancer Discov"},{"issue":"3","key":"304_CR9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.molcel.2007.01.003","volume":"25","author":"A Ciccia","year":"2007","unstructured":"Ciccia A, Ling C, Coulthard R et al (2007) Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM. Mol Cell 25(3):331\u2013343. https:\/\/doi.org\/10.1016\/j.molcel.2007.01.003","journal-title":"Mol Cell"},{"issue":"R1","key":"304_CR10","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1093\/hmg\/ddm026","volume":"16","author":"N Rahman","year":"2007","unstructured":"Rahman N, Scott RH (2007) Cancer genes associated with phenotypes in monoallelic and biallelic mutation carriers: new lessons from old players. Hum Mol Genet 16(R1):R60\u2013R66. https:\/\/doi.org\/10.1093\/hmg\/ddm026","journal-title":"Hum Mol Genet"},{"issue":"5","key":"304_CR11","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1056\/NEJMoa1913948","volume":"384","author":"Consortium BCA","year":"2021","unstructured":"Consortium BCA (2021) Breast cancer risk genes\u2014association analysis in more than 113,000 women. N Engl J Med 384(5):428\u2013439. https:\/\/doi.org\/10.1056\/NEJMoa1913948","journal-title":"N Engl J Med"},{"issue":"42","key":"304_CR12","doi-asserted-by":"publisher","first-page":"15172","DOI":"10.1073\/pnas.1407909111","volume":"111","author":"JI Kiiski","year":"2014","unstructured":"Kiiski JI, Pelttari LM, Khan S et al (2014) Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer. Proc Natl Acad Sci USA 111(42):15172\u201315177. https:\/\/doi.org\/10.1073\/pnas.1407909111","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"304_CR13","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1001\/jamaoncol.2016.5592","volume":"3","author":"G Neidhardt","year":"2017","unstructured":"Neidhardt G, Hauke J, Ramser J et al (2017) Association Between Loss-of-Function Mutations Within the FANCM Gene and Early-Onset Familial Breast Cancer. JAMA Oncol 3(9):1245\u20131248. https:\/\/doi.org\/10.1001\/jamaoncol.2016.5592","journal-title":"JAMA Oncol"},{"issue":"18","key":"304_CR14","doi-asserted-by":"publisher","first-page":"5345","DOI":"10.1093\/hmg\/ddv251","volume":"24","author":"P Peterlongo","year":"2015","unstructured":"Peterlongo P, Catucci I, Colombo M et al (2015) FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor. Hum Mol Genet 24(18):5345\u20135355. https:\/\/doi.org\/10.1093\/hmg\/ddv251","journal-title":"Hum Mol Genet"},{"issue":"31","key":"304_CR15","doi-asserted-by":"publisher","first-page":"50930","DOI":"10.18632\/oncotarget.15871","volume":"8","author":"E Dicks","year":"2017","unstructured":"Dicks E, Song H, Ramus SJ et al (2017) Germline whole exome sequencing and large-scale replication identifies FANCM as a likely high grade serous ovarian cancer susceptibility gene. Oncotarget 8(31):50930\u201350940. https:\/\/doi.org\/10.18632\/oncotarget.15871","journal-title":"Oncotarget"},{"issue":"6","key":"304_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178450","volume":"12","author":"JL Stafford","year":"2017","unstructured":"Stafford JL, Dyson G, Levin NK et al (2017) Reanalysis of BRCA1\/2 negative high risk ovarian cancer patients reveals novel germline risk loci and insights into missing heritability. PLoS ONE 12(6):e0178450. https:\/\/doi.org\/10.1371\/journal.pone.0178450","journal-title":"PLoS ONE"},{"issue":"1","key":"304_CR17","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10549-015-3457-5","volume":"152","author":"MU Rashid","year":"2015","unstructured":"Rashid MU, Muhammad N, Khan FA, Hamann U (2015) Absence of the FANCM c.5101C>T mutation in BRCA1\/2-negative triple-negative breast cancer patients from Pakistan. Breast Cancer Res Treat 152(1):229\u2013230. https:\/\/doi.org\/10.1007\/s10549-015-3457-5","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"304_CR18","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1002\/ijc.22269","volume":"119","author":"MU Rashid","year":"2006","unstructured":"Rashid MU, Zaidi A, Torres D et al (2006) Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients. Int J Cancer 119(12):2832\u20132839. https:\/\/doi.org\/10.1002\/ijc.22269","journal-title":"Int J Cancer"},{"key":"304_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13053-019-0125-5","volume":"17","author":"MU Rashid","year":"2019","unstructured":"Rashid MU, Muhammad N, Naeemi H et al (2019) Spectrum and prevalence of BRCA1\/2 germline mutations in Pakistani breast cancer patients: results from a large comprehensive study. Hered cancer clin pract 17:27. https:\/\/doi.org\/10.1186\/s13053-019-0125-5","journal-title":"Hered cancer clin pract"},{"issue":"2","key":"304_CR20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10549-016-4044-0","volume":"161","author":"MU Rashid","year":"2017","unstructured":"Rashid MU, Muhammad N, Amin A, Loya A, Hamann U (2017) Contribution of BRCA1 large genomic rearrangements to early-onset and familial breast\/ovarian cancer in Pakistan. Breast Cancer Res Treat 161(2):191\u2013201. https:\/\/doi.org\/10.1007\/s10549-016-4044-0","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"304_CR21","doi-asserted-by":"publisher","first-page":"992","DOI":"10.4143\/crt.2018.356","volume":"51","author":"MU Rashid","year":"2019","unstructured":"Rashid MU, Khan FA, Muhammad N, Loya A, Hamann U (2019) Prevalence of PALB2 germline mutations in early-onset and familial breast\/ovarian cancer patients from Pakistan. Cancer Res Treat 51(3):992\u20131000. https:\/\/doi.org\/10.4143\/crt.2018.356","journal-title":"Cancer Res Treat"},{"key":"304_CR22","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/1471-2407-13-312","volume":"13","author":"MU Rashid","year":"2013","unstructured":"Rashid MU, Muhammad N, Faisal S, Amin A, Hamann U (2013) Constitutional CHEK2 mutations are infrequent in early-onset and familial breast\/ovarian cancer patients from Pakistan. BMC Cancer 13:312. https:\/\/doi.org\/10.1186\/1471-2407-13-312","journal-title":"BMC Cancer"},{"issue":"3","key":"304_CR23","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s10549-014-2972-0","volume":"145","author":"MU Rashid","year":"2014","unstructured":"Rashid MU, Muhammad N, Faisal S, Amin A, Hamann U (2014) Deleterious RAD51C germline mutations rarely predispose to breast and ovarian cancer in Pakistan. Breast Cancer Res Treat 145(3):775\u2013784. https:\/\/doi.org\/10.1007\/s10549-014-2972-0","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"304_CR24","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s10689-012-9509-7","volume":"11","author":"MU Rashid","year":"2012","unstructured":"Rashid MU, Gull S, Asghar K, Muhammad N, Amin A, Hamann U (2012) Prevalence of TP53 germ line mutations in young Pakistani breast cancer patients. Fam Cancer 11(2):307\u2013311. https:\/\/doi.org\/10.1007\/s10689-012-9509-7","journal-title":"Fam Cancer"},{"issue":"1","key":"304_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13053-020-00159-6","volume":"18","author":"MU Rashid","year":"2020","unstructured":"Rashid MU, Muhammad N, Khan FA et al (2020) Prevalence of RECQL germline variants in Pakistani early-onset and familial breast cancer patients. Hered cancer clin pract 18(1):25. https:\/\/doi.org\/10.1186\/s13053-020-00159-6","journal-title":"Hered cancer clin pract"},{"issue":"1","key":"304_CR26","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1186\/s12885-016-2698-y","volume":"16","author":"MU Rashid","year":"2016","unstructured":"Rashid MU, Muhammad N, Bajwa S et al (2016) High prevalence and predominance of BRCA1 germline mutations in Pakistani triple-negative breast cancer patients. BMC Cancer 16(1):673. https:\/\/doi.org\/10.1186\/s12885-016-2698-y","journal-title":"BMC Cancer"},{"issue":"10","key":"304_CR27","doi-asserted-by":"publisher","first-page":"e0141562","DOI":"10.1371\/journal.pone.0141562","volume":"10","author":"MU Rashid","year":"2015","unstructured":"Rashid MU, Muzaffar M, Khan FA et al (2015) Association between the BsmI Polymorphism in the Vitamin D Receptor Gene and breast cancer risk: results from a Pakistani case-control study. PLoS ONE 10(10):e0141562. https:\/\/doi.org\/10.1371\/journal.pone.0141562","journal-title":"PLoS ONE"},{"issue":"5","key":"304_CR28","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Gene Med 17(5):405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Gene Med"},{"issue":"11","key":"304_CR29","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1093\/carcin\/bgp218","volume":"30","author":"MJ Garc\u00eda","year":"2009","unstructured":"Garc\u00eda MJ, Fern\u00e1ndez V, Osorio A et al (2009) Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1\/BRCA2 plays a major role in high-risk breast cancer predisposition. Carcinogenesis 30(11):1898\u20131902. https:\/\/doi.org\/10.1093\/carcin\/bgp218","journal-title":"Carcinogenesis"},{"issue":"5","key":"304_CR30","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00439-011-0951-7","volume":"129","author":"MR Akbari","year":"2011","unstructured":"Akbari MR, Malekzadeh R, Lepage P et al (2011) Mutations in Fanconi anemia genes and the risk of esophageal cancer. Hum Genet 129(5):573\u2013582. https:\/\/doi.org\/10.1007\/s00439-011-0951-7","journal-title":"Hum Genet"},{"key":"304_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12040829","author":"J Del Valle","year":"2020","unstructured":"Del Valle J, Rofes P (2020) Exploring the role of mutations in fanconi anemia genes in hereditary cancer patients. Cancers. https:\/\/doi.org\/10.3390\/cancers12040829","journal-title":"Cancers"},{"issue":"12","key":"304_CR32","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1007\/s00432-018-2763-9","volume":"144","author":"S Bonache","year":"2018","unstructured":"Bonache S, Esteban I, Moles-Fern\u00e1ndez A et al (2018) Multigene panel testing beyond BRCA1\/2 in breast\/ovarian cancer spanish families and clinical actionability of findings. J Cancer Res Clin Oncol 144(12):2495\u20132513. https:\/\/doi.org\/10.1007\/s00432-018-2763-9","journal-title":"J Cancer Res Clin Oncol"},{"issue":"11","key":"304_CR33","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1002\/ijc.31992","volume":"144","author":"S Schubert","year":"2019","unstructured":"Schubert S, van Luttikhuizen JL, Auber B et al (2019) The identification of pathogenic variants in BRCA1\/2 negative, high risk, hereditary breast and\/or ovarian cancer patients: high frequency of FANCM pathogenic variants. Int J Cancer 144(11):2683\u20132694. https:\/\/doi.org\/10.1002\/ijc.31992","journal-title":"Int J Cancer"},{"issue":"1","key":"304_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12881-018-0524-x","volume":"19","author":"T Nguyen-Dumont","year":"2018","unstructured":"Nguyen-Dumont T, Myszka A, Karpinski P et al (2018) FANCM and RECQL genetic variants and breast cancer susceptibility: relevance to South Poland and West Ukraine. BMC Med Genet 19(1):12. https:\/\/doi.org\/10.1186\/s12881-018-0524-x","journal-title":"BMC Med Genet"},{"issue":"10","key":"304_CR35","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1002\/ijc.32309","volume":"145","author":"A Nurmi","year":"2019","unstructured":"Nurmi A, Muranen TA, Pelttari LM et al (2019) Recurrent moderate-risk mutations in Finnish breast and ovarian cancer patients. Int J Cancer 145(10):2692\u20132700. https:\/\/doi.org\/10.1002\/ijc.32309","journal-title":"Int J Cancer"},{"issue":"4","key":"304_CR36","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/cge.12748","volume":"90","author":"F Lhota","year":"2016","unstructured":"Lhota F, Zemankova P, Kleiblova P et al (2016) Hereditary truncating mutations of DNA repair and other genes in BRCA1\/BRCA2\/PALB2-negatively tested breast cancer patients. Clin Genet 90(4):324\u2013333. https:\/\/doi.org\/10.1111\/cge.12748","journal-title":"Clin Genet"},{"issue":"2","key":"304_CR37","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/gcc.22911","volume":"60","author":"M Cavaill\u00e9","year":"2021","unstructured":"Cavaill\u00e9 M, Uhrhammer N, Privat M et al (2021) Analysis of 11 candidate genes in 849 adult patients with suspected hereditary cancer predisposition. Genes Chromosom Cancer 60(2):73\u201378. https:\/\/doi.org\/10.1002\/gcc.22911","journal-title":"Genes Chromosom Cancer"},{"issue":"1","key":"304_CR38","doi-asserted-by":"publisher","first-page":"19986","DOI":"10.1038\/s41598-019-55515-x","volume":"9","author":"E Jarhelle","year":"2019","unstructured":"Jarhelle E, Riise Stensland HMF, Hansen G\u00c5M et al (2019) Identifying sequence variants contributing to hereditary breast and ovarian cancer in BRCA1 and BRCA2 negative breast and ovarian cancer patients. Sci Rep 9(1):19986. https:\/\/doi.org\/10.1038\/s41598-019-55515-x","journal-title":"Sci Rep"},{"issue":"2","key":"304_CR39","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s10549-015-3545-6","volume":"153","author":"MS Ellingson","year":"2015","unstructured":"Ellingson MS, Hart SN, Kalari KR et al (2015) Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy. Breast Cancer Res Treat 153(2):435\u2013443. https:\/\/doi.org\/10.1007\/s10549-015-3545-6","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"304_CR40","doi-asserted-by":"publisher","first-page":"e55681","DOI":"10.1371\/journal.pone.0055681","volume":"8","author":"FJ Gracia-Aznarez","year":"2013","unstructured":"Gracia-Aznarez FJ, Fernandez V, Pita G et al (2013) Whole exome sequencing suggests much of non-BRCA1\/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles. PLoS ONE 8(2):e55681. https:\/\/doi.org\/10.1371\/journal.pone.0055681","journal-title":"PLoS ONE"},{"key":"304_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-019-0127-5","author":"G Figlioli","year":"2019","unstructured":"Figlioli G, Bogliolo M, Catucci I, Caleca L (2019) The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer. NPJ Breast Cancer. https:\/\/doi.org\/10.1038\/s41523-019-0127-5","journal-title":"NPJ Breast Cancer"},{"key":"304_CR42","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/1471-2407-11-209","volume":"11","author":"L Mirabello","year":"2011","unstructured":"Mirabello L, Yu K, Berndt SI et al (2011) A comprehensive candidate gene approach identifies genetic variation associated with osteosarcoma. BMC Cancer 11:209. https:\/\/doi.org\/10.1186\/1471-2407-11-209","journal-title":"BMC Cancer"},{"issue":"5","key":"304_CR43","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1093\/hmg\/7.5.919","volume":"7","author":"MQ Zhang","year":"1998","unstructured":"Zhang MQ (1998) Statistical features of human exons and their flanking regions. Hum Mol Genet 7(5):919\u2013932. https:\/\/doi.org\/10.1093\/hmg\/7.5.919","journal-title":"Hum Mol Genet"},{"issue":"13","key":"304_CR44","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1093\/nar\/gkm402","volume":"35","author":"E Buratti","year":"2007","unstructured":"Buratti E, Chivers M, Kr\u00e1lovicov\u00e1 J et al (2007) Aberrant 5\u2019 splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization. Nucleic Acids Res 35(13):4250\u20134263. https:\/\/doi.org\/10.1093\/nar\/gkm402","journal-title":"Nucleic Acids Res"},{"key":"304_CR45","doi-asserted-by":"publisher","DOI":"10.1385\/1-59259-432-8:9","author":"CF Taylor","year":"2004","unstructured":"Taylor CF, Taylor GR (2004) Current and emerging techniques for diagnostic mutation detection. Mol Diagn Genet Dis. https:\/\/doi.org\/10.1385\/1-59259-432-8:9","journal-title":"Mol Diagn Genet Dis"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-022-00304-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-022-00304-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-022-00304-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T15:46:31Z","timestamp":1673624791000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-022-00304-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,8]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["304"],"URL":"https:\/\/doi.org\/10.1007\/s10689-022-00304-1","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"type":"print","value":"1389-9600"},{"type":"electronic","value":"1573-7292"}],"subject":[],"published":{"date-parts":[[2022,7,8]]},"assertion":[{"value":"28 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Conflict of interest relevant to this article was not reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Written informed consent was obtained from all study participants included in the study. The study was approved by the Institutional Review Board (IRB) of SKMCH&RC (IRB approval number ONC-BRCA-001\/2).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}